Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry, immunoassay, or other means.
Type:
Application
Filed:
September 11, 2009
Publication date:
February 25, 2010
Applicants:
Vermillion, Inc., Sahlgrenska Academy at Goeteborg University
Inventors:
Eric T. Fung, Tai-Tung Yip, Vladimir Podust, Mats Brannstrom, Karin Sundfeldt, Bjorg Kristjansdottir
Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry, immunoassay, or other means.
Type:
Application
Filed:
March 27, 2008
Publication date:
November 6, 2008
Applicants:
Vermillion, Inc., Sahlgrenska Academy at Goeteborg University
Inventors:
Eric T. Fung, Tai-Tung Yip, Vladimir Podust, Mats Brannstrom, Karin Sundfeldt, Bjorg Kristjansdottir